Nephrogenic fibrosing dermopathy: a novel cutaneous fibrosing disorder in patients with renal failure. (Q47904235)

6 February 2018

title

Nephrogenic fibrosing dermopathy: a novel cutaneous fibrosing disorder in patients with renal failure. (English)

1 reference

6 February 2018

0 references

3

1 reference

6 February 2018

Leslie J. Crofford

2

object named as

Leslie J Crofford

1 reference

6 February 2018

author name string

Richard D Swartz

1

1 reference

6 February 2018

Robert W Ike

4

1 reference

6 February 2018

Lyndon D Su

5

1 reference

6 February 2018

language of work or name

English

0 references

publication date

1 May 2003

1 reference

6 February 2018

American Journal of Medicine

published in

1 reference

6 February 2018

volume

114

1 reference

6 February 2018

issue

7

1 reference

6 February 2018

page(s)

563-572

1 reference

6 February 2018

Nephrogenic fibrosing dermopathy

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2803%2900085-8

Scleromyxoedema-like cutaneous diseases in renal-dialysis patients

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2803%2900085-8

The association of potentially lethal neurologic syndromes with scleromyxedema (papular mucinosis).

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2803%2900085-8

Fatal scleromyxedema: report of a case and review of the literature

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2803%2900085-8

Updated classification of papular mucinosis, lichen myxedematosus, and scleromyxedema.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2803%2900085-8

Modulated response to cytokines of human wound healing myofibroblasts compared to dermal fibroblasts

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2803%2900085-8

Keloids and hypertrophic scars of Caucasians show distinctive morphologic and immunophenotypic profiles

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2803%2900085-8

Myofibroblasts from scleroderma skin synthesize elevated levels of collagen and tissue inhibitor of metalloproteinase (TIMP-1) with two forms of TIMP-1.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2803%2900085-8

IL-1 rescues scleroderma myofibroblasts from serum-starvation-induced cell death

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2803%2900085-8

Transforming growth factor-beta 1 induces alpha-smooth muscle actin expression in granulation tissue myofibroblasts and in quiescent and growing cultured fibroblasts

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2803%2900085-8

GM-CSF-induced granulation tissue formation: relationships between macrophage and myofibroblast accumulation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2803%2900085-8

Role of cytokines and cytokine therapy in wound healing and fibrotic diseases

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2803%2900085-8

Apoptosis during wound healing, fibrocontractive diseases and vascular wall injury

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2803%2900085-8

Inhibition of myofibroblast apoptosis by transforming growth factor beta(1)

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2803%2900085-8

Inclusion Body Myofibroblasts Other than Those Seen in Recurring Digital Fibroma of Childhood

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2803%2900085-8

10.1016/S0002-9343(03)00085-8

7 January 2021

Identifiers

DOI

1 reference

6 February 2018

PubMed ID

12753880

1 reference

6 February 2018